AG Pharma’s commitment to inventive drug development brings brighter tomorrows to patients everywhere. We develop breakthrough pharmaceutical innovations that improve patient outcomes worldwide.
Our proprietary monoclonal antibody against human for research use in breast cancer, other cancers, and diseases.
Read More
About Us
AG Pharma is a theranostics company focused on developing monoclonal antibodies against cancer-specific targets as the foundation for novel therapeutic and diagnostic products. By using tumor-specific biomarkers, our approach selectively restricts the drivers of tumor growth, enabling more personalized and effective care for cancer patients.
At AG Pharma, we’re ushering in a more personalized approach to treating cancer and other serious diseases by harnessing the power of antibodies to selectively recognize and bind to the specific cell-surface biomarkers that distinguish diseased cells from normal cells.
Using the tumor-specific biomarkers as targets, we are engineering a new generation of therapeutics that selectively strike the causes of tumor growth, while concurrently developing FDA-approved “companion” diagnostic tests that reliably reveal the specific cancer long before it reveals itself, identify patients that will respond to the associated targeted therapy, predict recurrence, and monitor response to treatment.
Our comprehensive range of medicines addresses critical health challenges, ensuring accessibility and affordability for all.
Our comprehensive range of medicines addresses critical health challenges, ensuring accessibility and affordability for all.
Our comprehensive range of medicines addresses critical health challenges, ensuring accessibility and affordability for all.
Our comprehensive range of medicines addresses critical health challenges, ensuring accessibility and affordability for all.
AG Pharma Theranostic (Rx-Dx) Development
Overview
AG Pharma’s approach is to develop linked diagnostic-therapeutic products using the company’s proprietary biomarker discovery platform.
Companion Diagnostics
Detect and monitor levels of cancer-specific biomarkers discovered by AG Pharma.
Targeted Therapeutics
Engineered to precisely target the unique type of tumor or disease cell.
Advancing a New Treatment Paradigm
Our theranostics program illustrates how co-development of a targeted therapeutic with companion diagnostic tests advances a powerful new treatment approach.
Leadership & Expertise
AG Pharma’s scientific leadership includes world-leading researchers in cell biology, immunology, and growth factor research, and the company has broad expertise in molecular biology and biochemistry, providing a strong foundation for developing new drug/test products that improve cancer detection, treatment, survival, and outcomes, delivering on the promise of personalized cancer care.
Precision Pipeline
AG Pharma develops linked diagnostic-therapeutic products based on cancer-specific biomarkers discovered through its proprietary platform. These Rx-Dx tandems enable more effective individualized treatment by helping physicians detect disease earlier, identify patients at high risk of recurrence/mortality, select optimal treatments, target disease-driving mechanisms, monitor therapy response, detect resistance, and track recurrence.
Testimonials
Our legacy of trust and innovation is supported by strong partnerships with leading healthcare providers and institutions.
Healthcare Professional
AG Pharma has been a trusted partner for years. Their commitment to quality
and innovation is unparalleled, and their products have significantly improved
the lives of our patients.
Healthcare Professional
AG Pharma has been a trusted partner for years. Their commitment to quality
and innovation is unparalleled, and their products have significantly improved
the lives of our patients.
Healthcare Professional
AG Pharma has been a trusted partner for years. Their commitment to quality
and innovation is unparalleled, and their products have significantly improved
the lives of our patients.
Healthcare Professional
AG Pharma has been a trusted partner for years. Their commitment to quality
and innovation is unparalleled, and their products have significantly improved
the lives of our patients.
Healthcare Professional
AG Pharma has been a trusted partner for years. Their commitment to quality
and innovation is unparalleled, and their products have significantly improved
the lives of our patients.
Get the latest breakthroughs in theranostics and targeted cancer care delivered right to your inbox. We’ll share updates on our clinical trials, new biomarker discoveries, and the integration of diagnostics and therapeutics that are transforming oncology.
